Company Profile

Macrocure Ltd. is a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).

Read More

NASDAQ: MCUR

$ 1.45
+ 0.03 (+2.11%)
Day High: 1.45
Day Low:  1.41
Volume:    30,953
3:59 PM ET on Sep 23, 2016

Delayed at least 20 minutes.